Risperidone and Ampyra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Risperidone (risperidone) and Ampyra (dalfampridine). Common drug interactions include tongue blistering among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Risperidone and Ampyra. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Risperidone?

Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 72,175 Risperidone users. Check the latest studies of Risperidone.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.



On Jul, 26, 2026

91 people who take Risperidone and Ampyra together, and have interactions are studied.

Risperidone and Ampyra drug interactions.

What are the common drug interactions of Risperidone and Ampyra, by gender? *:

female:

  1. Tongue blistering
  2. Vomiting
  3. Asthenia (weakness)
  4. Diarrhoea
  5. Eye disorder
  6. Gastric dilatation (a twisted stomach)
  7. Hepatic enzyme increased
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Type 2 diabetes mellitus
  10. Vertigo

male:

  1. Fall
  2. Mobility decreased (ability to move is reduced)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Headache (pain in head)
  5. Muscular weakness (muscle weakness)
  6. Nausea (feeling of having an urge to vomit)
  7. Eye movement disorder
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Dizziness
  10. Dysstasia (difficulty in standing)

What are the common drug interactions of Risperidone and Ampyra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal discomfort
  2. Flushing (the warm, red condition of human skin)
  3. Hepatic enzyme increased

30-39:

  1. Mobility decreased (ability to move is reduced)
  2. Arthralgia (joint pain)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Limb discomfort (discomfort in leg)
  7. Joint injury
  8. Gait disturbance
  9. Balance disorder
  10. Muscular weakness (muscle weakness)

40-49:

  1. Balance disorder
  2. Fatigue (feeling of tiredness)
  3. Ligament sprain (ligament stretched)
  4. Memory impairment
  5. Onychomycosis (fungal infection of the nail)
  6. Thermohypoaesthesia (a reduced sense of touch or sensation, or a partial loss of sensitivity to sensory stimuli heat)
  7. Arthralgia (joint pain)
  8. Blood sodium decreased
  9. Confusional state
  10. Dysarthria (speech disorder)

50-59:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Weight increased
  3. Urinary tract infection
  4. Memory impairment
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Dizziness
  9. Abasia (inability to walk)
  10. Intervertebral disc protrusion (spinal disc protrusion)

60+:

  1. Back pain
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Muscular weakness (muscle weakness)
  4. Muscle spasms (muscle contraction)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Gait disturbance
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Hepatic enzyme increased
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

  1. Gait Disturbance: 27 people, 29.67%

* Approximation only. Some reports may have incomplete information.

Do you take Risperidone and Ampyra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Risperidone and Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Risperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ampyra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ampyra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on risperidone and dalfampridine (the active ingredients of Risperidone and Ampyra, respectively), and Risperidone and Ampyra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: